Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease

In chronic obstructive pulmonary disease (COPD), treatment with inhaled corticosteroids (ICSs) in combination with long acting beta-2-agonists (LABA) or LABA/long-acting muscarinic antagonists (LAMA) is used in order to reduce exacerbations. Treatment with ICS is, however, associated with side effec...

Descripción completa

Detalles Bibliográficos
Autor principal: Janson, Christer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212119/
https://www.ncbi.nlm.nih.gov/pubmed/32395293
http://dx.doi.org/10.21037/jtd.2020.02.51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212119/
https://www.ncbi.nlm.nih.gov/pubmed/32395293
http://dx.doi.org/10.21037/jtd.2020.02.51

Ejemplares similares